8.25.2007
The Pharma Giants: Ready for the 21st Century?
The Pharma Giants: Ready for the 21st Century?: "Presents the changing competitive dynamics in the global pharmaceutical industry and possible implications for large drug companies."
skip to main |
skip to sidebar
Blog Archive
-
►
2013
(14)
- ► 05/05 - 05/12 (1)
- ► 04/07 - 04/14 (9)
- ► 03/31 - 04/07 (1)
- ► 03/10 - 03/17 (3)
-
►
2010
(4)
- ► 06/13 - 06/20 (1)
- ► 01/31 - 02/07 (2)
- ► 01/10 - 01/17 (1)
-
►
2009
(22)
- ► 09/20 - 09/27 (2)
- ► 09/06 - 09/13 (1)
- ► 08/09 - 08/16 (1)
- ► 08/02 - 08/09 (1)
- ► 07/12 - 07/19 (1)
- ► 05/10 - 05/17 (2)
- ► 04/19 - 04/26 (5)
- ► 04/12 - 04/19 (1)
- ► 04/05 - 04/12 (7)
- ► 03/01 - 03/08 (1)
-
►
2008
(290)
- ► 12/28 - 01/04 (2)
- ► 12/21 - 12/28 (4)
- ► 12/14 - 12/21 (2)
- ► 11/23 - 11/30 (1)
- ► 10/26 - 11/02 (5)
- ► 10/19 - 10/26 (5)
- ► 10/12 - 10/19 (55)
- ► 10/05 - 10/12 (1)
- ► 09/28 - 10/05 (1)
- ► 09/21 - 09/28 (45)
- ► 09/14 - 09/21 (3)
- ► 08/31 - 09/07 (5)
- ► 08/24 - 08/31 (20)
- ► 08/17 - 08/24 (3)
- ► 08/10 - 08/17 (1)
- ► 08/03 - 08/10 (3)
- ► 07/13 - 07/20 (1)
- ► 07/06 - 07/13 (2)
- ► 06/29 - 07/06 (13)
- ► 06/15 - 06/22 (2)
- ► 06/08 - 06/15 (2)
- ► 06/01 - 06/08 (2)
- ► 05/25 - 06/01 (7)
- ► 05/18 - 05/25 (7)
- ► 05/11 - 05/18 (1)
- ► 04/27 - 05/04 (9)
- ► 04/20 - 04/27 (22)
- ► 04/13 - 04/20 (11)
- ► 04/06 - 04/13 (20)
- ► 03/30 - 04/06 (4)
- ► 03/23 - 03/30 (1)
- ► 03/16 - 03/23 (1)
- ► 03/09 - 03/16 (1)
- ► 02/24 - 03/02 (3)
- ► 02/17 - 02/24 (10)
- ► 02/10 - 02/17 (5)
- ► 02/03 - 02/10 (2)
- ► 01/27 - 02/03 (3)
- ► 01/13 - 01/20 (4)
- ► 01/06 - 01/13 (1)
-
▼
2007
(1218)
- ► 12/16 - 12/23 (4)
- ► 12/02 - 12/09 (5)
- ► 11/25 - 12/02 (4)
- ► 11/18 - 11/25 (22)
- ► 11/11 - 11/18 (31)
- ► 11/04 - 11/11 (10)
- ► 10/28 - 11/04 (4)
- ► 10/21 - 10/28 (15)
- ► 10/14 - 10/21 (31)
- ► 10/07 - 10/14 (85)
- ► 09/30 - 10/07 (129)
- ► 09/23 - 09/30 (23)
- ► 09/16 - 09/23 (98)
- ► 09/09 - 09/16 (116)
- ► 09/02 - 09/09 (52)
- ► 08/26 - 09/02 (57)
-
▼
08/19 - 08/26
(52)
- Venture Capital Basics � SlideShare
- Science Business: The Promise, the Reality, and th...
- Enbrel: The Sting of Success
- Bayer & Millennium Pharmaceuticals: Success Based ...
- Survivor Scios: Reality Biotech--The Anatomy of a ...
- Connetics and Relaxin
- Bio-Tech, Inc.
- Race to Develop Human Insulin
- Kevin Simpson
- ImmuLogic Pharmaceutical Corp. (A): March 1991
- ImmuLogic Pharmaceutical Corp. (Abridged)
- ALZA and Bio-Electro Systems (A): Technological an...
- Genzyme Corp.: Strategic Challenges with Ceredase
- Chiron Corp.
- Genzyme Corp.: A Financing History
- Repligen Corp.: January 1992
- Aberlyn Capital Management: July 1993
- Alpha-Beta Technology, Inc.: Pioneering Carbohydra...
- Kevin Simpson at Haemonetics, Video
- The Money Connection—Understanding VC Networks Pub...
- Banking Deregulation, Financing Constraints and En...
- Report from China: The New Entrepreneurs Published...
- Cephalon, Inc.
- The Pharma Giants: Ready for the 21st Century?
- Gene Research, the Mapping of Life and the Global ...
- Novartis: Betting on Life Sciences
- Medi-Cult: Pricing a Radical Innovation
- Monsanto and the Global Water Treatment Industry
- Strategic Deal Making at Millennium Pharmaceuticals
- When the Boss Won't Budge (HBR Case Study and Comm...
- Transforming Life, Transforming Business: The Life...
- Biogen Unchained
- Monsanto's Genetically Modified Organisms: The Bat...
- Pharmacyclics: Financing Research & Development
- Abgenix and the XenoMouse
- DNA: Handle with Care
- Robert Shapiro and Monsanto
- Diagnostic Genomics
- Centagenetix (A): Building a Business Model for Ge...
- Proteome Systems Ltd.
- Perlegen Sciences
- Calgene, Inc.
- E.I. du Pont de Nemours and Co.: The Conoco Split-...
- The Life Sciences Revolution: A Technical Primer
- Four VCs on Evaluating Opportunities — HBS Working...
- International Financial Integration and Entreprene...
- Surviving Success: When Founders Must Go — HBS Wor...
- NeuroTherapy Ventures: Catalyzing Neurologic Innov...
- Genzyme: Engineering the Market for Orphan Drugs
- In Vivo to in Vitro to in Silico: Coping with Tida...
- What Price Tranquility? $100 Million - Forbes.com
- White Paper
- ► 07/29 - 08/05 (40)
- ► 07/22 - 07/29 (173)
- ► 07/15 - 07/22 (24)
- ► 07/08 - 07/15 (10)
- ► 05/06 - 05/13 (7)
- ► 04/29 - 05/06 (76)
- ► 04/22 - 04/29 (150)